ArticleOncology letters2023

Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial.

Kequan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.